ѪҺѧרҵ´Ê»ã£¨ËÄ£©--±±¾©·Ò빫˾±¨¼Û
ѪҺѧרҵ´Ê»ã£¨ËÄ£©--±±¾©·Ò빫˾
±±¾©°Ùº½·Ò빫˾±à¼ÕûÀí
ChronicÂýÐÔµÄ
C.I.£ºcontinuous infusion£¬³ÖÐø¾²ÂöµãµÎ
CIK£ºcytokine-induced killer cells ϸ°ûÒò×ÓÓÕµ¼µÄɱÉËϸ°û
CliniMACS£ºclinical magnetic activated cell sorting£¬ÁÙ´²¼¶´ÅÐԻϸ°û·Öѡϵͳ
CLL£ºchronic lymphocytic leukemia£¬ÂýÐÔÁÜ°Íϸ°û°×Ѫ²¡
CML£ºchronic myelogenous leukemia£¬ÂýÐÔÁ£Ï¸°û°×Ѫ²¡
CML£AP£ºCML-accelerated phase£¬ÂýÐÔÁ£Ï¸°û°×Ѫ²¡¼ÓËÙÆÚ
CML£BP£ºCML-blastic phase£¬ÂýÐÔÁ£Ï¸°û°×Ѫ²¡¼±±äÆÚ
CML£CP£ºCML-chronic phase£¬ÂýÐÔÁ£Ï¸°û°×Ѫ²¡ÂýÐÔÆÚ
CMML£ºchronic myelo-monocytic leukemia£¬ÂýÐÔÁ£-µ¥Ï¸°û°×Ѫ²¡
CMPD£ºchronic myeloproliferative disease£¬ÂýÐÔ¹ÇËèÔöÉúÐÔ¼²²¡
CMV£ºcytomegalovirus£¬¾Þϸ°û²¡¶¾
CNR£ºcytokine negative response cell£¬Ï¸°ûÒò×Ó²»·´Ó¦Ï¸°û
CNS£ºcentral nervous system£¬ÖÐÊàÉñ¾ÏµÍ³
CNSL£ºcentral nervous system leukemia£¬ÖÐÊàÉñ¾ÏµÍ³°×Ѫ²¡
Collection: ²É¼¯
Colony stimulating factor£º¼¯Âä´Ì¼¤Òò×Ó
c-onc£ºcellular oncogene£¬Ï¸°û°©»ùÒò
Conditioning£ºÔ¤´¦Àí
Conjunctivitis£º½áĤÑ×
Convalescence£º»Ö¸´£¬»Ö¸´ÆÚ
CP£ºcancer procoagulant£¬°©ÐÔ´ÙÄýÎïÖÊ
CPD£ºcitrate phosphate dextrose£¬èÛéÚËáÑΣÁ×ËáÑΣÆÏÌÑÌÇ
CPDA£º citrate phosphate dextrose adenine£¬èÛéÚËáÑΣÁ×ËáÑΣÆÏÌÑÌÇ£ÏÙàÑßÊ
Cpmax£ºpeak concentration£¬·åŨ¶È
CPT£ºcamptothecine£¬Ï²Ê÷¼î
CR£ºcomplete remission£¬ÍêÈ«»º½â
CRABP£ºcytoplasmic retinoic acid binding protein£¬°û½¬Î¬¼×Ëá½áºÏµ°°×
CRP£ºC reaction protein,±û·´Ó¦µ°°×
CRR£ºcomplete remission rate£¬ÍêÈ«»º½âÂÊ
Cryopreservation£ºÀ䶳±£´æ£¬ÉîµÍα£²Ø
CSF£ºcolony stimulating factor£¬¼¯Âä´Ì¼¤Òò×Ó
CSF£ºcerebrospinal fluid£¬ÄÔ¼¹Òº
CTCL£ºcutaneous T cell lymphoma£¬Æ¤·ôTϸ°ûÁÜ°ÍÁö
CTCL£ºcentral T cell lymphoma£¬ÖÐÊàTϸ°ûÁÜ°ÍÁö
CTL£ºcytotoxicity T lymphocyte£¬Ï¸°û¶¾ÐÔTÁÜ°Íϸ°û
Cyclin£ºÖÜÆÚËØ
Cytomegalovirus£º¾Þϸ°û²¡¶¾
DC£ºdendric cell£¬Ê÷ͻϸ°û
D£D£ºD dimer£¬D£¶þ¾ÛÌå
Del£ºdeletion£¬È±Ê§
Dermatitis£ºÆ¤Ñ×
De nova AML£º·Ç¼Ì·¢ÐÔ¼±ÐÔËèÐÔ°×Ѫ²¡
DFS£ºdisease free survival£¬ÎÞ²¡Éú´æÆÚ
±±¾©·Ò빫˾---±±¾©°Ùº½·Òë